Home/Filings/4/0001213900-22-030914
4//SEC Filing

ADAMS ERIC A 4

Accession 0001213900-22-030914

CIK 0001728328other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 2:50 PM ET

Size

5.4 KB

Accession

0001213900-22-030914

Insider Transaction Report

Form 4
Period: 2022-06-02
ADAMS ERIC A
DirectorCEO & President10% Owner
Transactions
  • Expiration (Short)

    Employee Stock Option (Expiration)

    2022-06-0213,636337,576 total
    Exercise: $11.75From: 2017-06-02Exp: 2022-06-02Common shares (13,636 underlying)
Footnotes (1)
  • [F1]Converted from the Canadian dollar exercise price of C$14.85 using an exchange rate of C$1.2639 = $US1.00

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001817882

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 2:50 PM ET
Size
5.4 KB